APTV Aptiv PLC Insider Trading

Director Agnevall Hakan buys 6,100 shares of Aptiv at $57.73 as stock trades well below its 52-week high; second open-market purchase in 36 months.

Director Agnevall Hakan purchased a material quantity of shares while the stock is trading substantially below its 52-week high, suggesting a willingness to accumulate at depressed valuations. This is his second open-market purchase in the past three years, continuing a pattern of buying rather than selling. His prior purchase at this company showed early strength but reversed course over a longer timeframe, illustrating the mixed timing outcomes typical in volatile markets. Aptiv is a profitable enterprise with steady revenue growth, but is trading at a stretched valuation multiple, meaning this director is buying into fundamentals that haven't yet justified the price he paid. The purchase size represents a significant portion of his existing holdings, indicating material personal capital commitment rather than a token gesture.

Aptiv director Agnevall Hakan bought 3,700 shares at $80.25; holdings surge 387.4% to 4,655 shares

Director Agnevall Hakan purchased 3,700 shares at $80.25 on 2025-12-12, increasing his holdings from 955 shares to 4,655 shares—a net increase of 387.4%. The purchase occurred at a price $2.83 above the current market price of $77.42, placing the transaction near the 52-week high of $87.98 and 12.0% above current levels. Aptiv faces significant operational headwinds: the latest quarter showed net income of $-355.0M against revenue of $5.2B, and annual revenue growth stands at -1.7%, indicating a loss-making position despite substantial scale. The director's substantial accumulation—tripling his prior position—comes amid this deteriorating financial performance, warranting scrutiny of the strategic rationale for accumulation at elevated valuation.

CFO Laroyia Varun sells 14,500 shares of APTV at $77.88 for $1.1M; stock down -7.9% (30d), company posting -$355.0M net loss.

Laroyia Varun, EVP & Chief Financial Officer of Aptiv PLC, sold 14,500 shares at $77.88 on 2025-12-04, reducing his holdings by 8.5% to 155,769 shares post-transaction. The sale occurs against a backdrop of negative fundamentals: the company reported net income of -$355.0M in the latest quarter, annual revenue growth of -1.7%, and a P/E ratio of 56.26, suggesting either deep profitability concerns or market pricing challenges. The stock has declined -7.9% over the prior 30 days and is trading -12.4% below its 52-week high of $87.98, though the transaction price of $77.88 was above the current market price of $77.08. Within Varun's cross-ticker track record, his prior sells yielded an average 90-day return of +12.8%, a 0.00% well-timed rate—meaning his past sales coincided with subsequent stock appreciation rather than declines—yet this particular transaction's timing relative to APTV's forward trajectory remains to be determined.

EVP/CLO Katherine H Ramundo sells 13,000 APTV shares at $84.00; retains 122.0K post-sale

Ramundo, an executive officer (EVP, CLO, CCO & Secretary) at Aptiv, sold 13,000 shares at $84.00 on 2025-11-10, reducing her holdings by 9.6% from 135.0K to 122.0K shares. The sale occurred at a price $1.26 above the current price of $82.74 and near the 52-week high of $87.98. Notably, Aptiv faces operational headwinds: the company reported a net loss of -$355.0M in the latest quarter, annual revenue contracted -1.7% year-over-year, and the valuation multiple (P/E 60.39) is elevated for a company with negative earnings. While this represents a material reduction in personal stake by a senior executive responsible for legal and compliance matters, the transaction occurred at favorable pricing relative to recent market levels and does not constitute a full exit.

Vice Chairman Joseph R Massaro sold 35,000 APTV shares at $74.36 on 2025-08-21 for $2.6M; retains 329,392 shares.

Joseph R Massaro, Vice Chairman of ECG, executed an open-market sale of 35,000 shares at $74.36, reducing his position by 9.6% to 329,392 shares. The sale occurred when APTV was trading 5.47 points below its 52-week high of $78.83, and the stock has since rallied 11.2% in the 30 days following this transaction. Across Massaro's cross-ticker track record, his prior buys have yielded a 90-day average return of 13.7% with a 100% win rate, though this single sale represents his recent discretionary activity. With APTV trading near 52-week highs and the company posting $5.2B in quarterly revenue against a 16.95 P/E, the sale is modest relative to Massaro's substantial remaining shareholding of 329,392 shares, suggesting a partial position adjustment rather than portfolio exit.

SVP & CTO Lyon Benjamin sold 14,568 shares of APTV at $65.50; holds 125,237 shares post-sale.

Lyon Benjamin, SVP & CTO of Aptiv PLC, sold 14,568 shares on 2025-03-10 at $65.50, representing a 10.4% reduction in his holdings. The stock has since declined to $63.76, down 24.7% from its 52-week high of $84.65. His cross-ticker track record shows 2 prior sales with an average 90-day return of +4.8% and a 0.00% well-timed rate, indicating his prior sell-side timing has been poor (stock rose after his sales). At APTV specifically, his 2 prior sells in 2024 both yielded +4.8% average returns over 90 days, similarly poor timing patterns. The company itself shows modest fundamentals—annual revenue declined 1.7% year-over-year and trades at a P/E of 11.49—providing limited context for the sale motivation.

Aptiv CEO Clark buys 29.8K shares for $1.9M across 4 transactions; stock down 34.7% from 52-week high.

Kevin P. Clark, Chairman and CEO of Aptiv PLC, executed 4 separate open-market purchases totaling 29,770 shares for $1,948,562.65 at a blended average price of $65.45 on September 10-11, 2024. The stock is currently trading at $67.00, down 34.7% from its 52-week high of $102.67. His prior 5 trades at Aptiv were all sales in May 2023, none of which were well-timed at the 90-day mark—all generated positive subsequent returns, indicating he sold before the stock appreciated. The fundamental backdrop shows strong recent performance: FY revenue growth of +14.6%, a P/E of 4.83, and Q latest net income of $938.0M on $5.1B revenue. His holdings increased 8.9% to 363.9K shares post-transaction. This purchase pattern—multiple tranches at declining prices over two consecutive trading days during a significant drawdown from highs—warrants close observation against the historical record of his prior Aptiv sales, which failed to precede material declines.